Company Profile

Exscientia develops AI-driven drug discovery technology that uses generative design, machine learning, active learning, and automated analysis to design and prioritize potential drug molecules. Its platform combines computational models with laboratory experiments to explore chemical space and advance drug candidates for complex diseases.